Primapax’s life sciences financial advisory group provides strategic and tactical financial advisory services to pharmaceutical companies and investors in the Unites States and internationally. Our professionals have advised the senior management teams from a broad range of companies and have significant transactional and operating experience in specialty pharmaceuticals, biotechnology, medical devices and healthcare services. Primapax advises public and private companies on strategic partnering transactions, including product licensing, start-up, acquisitions, and divestitures.
Our financial advisory group was formed to fill in the gap that exists in the lower middle market and smaller divisions of large companies in addition to companies in the emerging markets. This section of the market is ignored by large investment banks whose focus is on servicing the larger companies in the life sciences space. We differentiate ourselves through our expert professionals with deep industry contacts, broad range of capital market contacts and focus on enabling the client to achieve their objectives with speed. We specialize in providing the following advisory and strategy services to the life sciences industries:
- – Business evaluation and capital Raising
- – Licensing and corporate partnerships
- – Initial Public Offerings and IPO readiness
- – Merger, Acquisition and Divestitures
- – Asset sale and liquidation
- – Management Consulting and strategy development